X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16559) 16559
Publication (1954) 1954
Book Chapter (151) 151
Book Review (147) 147
Newsletter (67) 67
Conference Proceeding (62) 62
Dissertation (22) 22
Book / eBook (14) 14
Magazine Article (13) 13
Data Set (6) 6
Newspaper Article (6) 6
Paper (3) 3
Government Document (2) 2
Reference (1) 1
Streaming Video (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10963) 10963
index medicus (9400) 9400
male (6762) 6762
female (6516) 6516
cerebrospinal fluid (6371) 6371
cerebrospinal-fluid (6198) 6198
neurosciences (5870) 5870
biomarkers (4913) 4913
middle aged (4508) 4508
clinical neurology (4248) 4248
aged (4241) 4241
alzheimer's disease (4139) 4139
biomarkers - cerebrospinal fluid (4126) 4126
adult (3252) 3252
diagnosis (2784) 2784
neurology (2630) 2630
dementia (2576) 2576
brain (2496) 2496
animals (2274) 2274
alzheimers-disease (2100) 2100
mild cognitive impairment (1926) 1926
aged, 80 and over (1886) 1886
alzheimer disease - cerebrospinal fluid (1868) 1868
biomarkers - blood (1797) 1797
analysis (1719) 1719
proteins (1691) 1691
amyloid beta-peptides - cerebrospinal fluid (1667) 1667
biomarker (1661) 1661
research (1594) 1594
tau proteins - cerebrospinal fluid (1588) 1588
magnetic resonance imaging (1521) 1521
alzheimer disease - diagnosis (1377) 1377
psychiatry (1372) 1372
neurodegenerative diseases (1307) 1307
article (1303) 1303
csf (1274) 1274
inflammation (1268) 1268
multiple sclerosis (1230) 1230
biological markers (1215) 1215
disease (1164) 1164
pathology (1164) 1164
enzyme-linked immunosorbent assay (1160) 1160
peptide fragments - cerebrospinal fluid (1154) 1154
tau (1078) 1078
adolescent (1069) 1069
disease progression (1069) 1069
immunology (1061) 1061
young adult (983) 983
plasma (981) 981
central-nervous-system (962) 962
medicine (952) 952
prognosis (946) 946
risk factors (929) 929
neurodegeneration (918) 918
mass spectrometry (915) 915
brain - pathology (907) 907
case-control studies (906) 906
alzheimers disease (892) 892
protein (889) 889
proteomics (885) 885
health aspects (879) 879
expression (877) 877
biochemistry & molecular biology (869) 869
medical research (867) 867
brain - metabolism (859) 859
cognitive ability (855) 855
care and treatment (848) 848
physiological aspects (841) 841
research article (834) 834
blood (824) 824
neuroimaging (823) 823
tau protein (819) 819
patients (807) 807
sensitivity and specificity (804) 804
serum (798) 798
development and progression (785) 785
alzheimer’s disease (761) 761
nervous system (757) 757
biomarkers - metabolism (753) 753
child (744) 744
cytokines (744) 744
parkinson's disease (743) 743
predictive value of tests (741) 741
oxidative stress (740) 740
multidisciplinary sciences (739) 739
studies (716) 716
neuropsychological tests (715) 715
biomarkers - analysis (705) 705
medicine, experimental (691) 691
central nervous system (688) 688
diagnosis, differential (685) 685
csf biomarkers (680) 680
multiple-sclerosis (679) 679
nervous system diseases (678) 678
alzheimer disease - pathology (670) 670
geriatrics & gerontology (665) 665
mice (660) 660
medicine & public health (641) 641
cell biology (640) 640
neurovetenskaper (636) 636
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16204) 16204
Japanese (197) 197
French (73) 73
Spanish (71) 71
German (69) 69
Russian (35) 35
Chinese (23) 23
Polish (22) 22
Portuguese (13) 13
Swedish (11) 11
Danish (8) 8
Czech (7) 7
Dutch (4) 4
Norwegian (4) 4
Finnish (3) 3
Italian (3) 3
Romanian (3) 3
Serbian (3) 3
Hungarian (2) 2
Korean (2) 2
Turkish (2) 2
Arabic (1) 1
Croatian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Trends in Pharmacological Sciences, ISSN 0165-6147, 2015, Volume 36, Issue 5, pp. 297 - 309
Journal Article
Trends in Pharmacological Sciences, ISSN 0165-6147, 05/2015, Volume 36, Issue 5, pp. 297 - 309
Aggregation of amyloid-β (Aβ) into oligomers, fibrils, and plaques is central in the molecular pathogenesis of Alzheimer's disease (AD), and is the main focus... 
biomarker | β-amyloid (Aβ) | positron emission tomography (PET) | Alzheimer's disease | cerebrospinal fluid | Neurologi | Clinical Medicine | Neurology | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Journal of Cellular and Molecular Medicine, ISSN 1582-1838, 08/2008, Volume 12, Issue 4, pp. 1094 - 1117
•  Introduction •  Pathogenesis of AD •  Alzheimer pathology and diagnosis •  Biomarkers of AD ‐  CSF biomarkers ‐  Plasma biomarkers ‐  Platelet biomarkers ‐ ... 
serum ELISA test | dementia | ALZAS protein | biomarker | Alzheimer disease | Biomarker | Serum ELISA test | Dementia | CSF-PHOSPHORYLATED-TAU | MEDICINE, RESEARCH & EXPERIMENTAL | MULTIPLE-SCLEROSIS LESIONS | TEMPORAL-LOBE ATROPHY | MILD COGNITIVE IMPAIRMENT | PLATELET MONOAMINE-OXIDASE | CELL BIOLOGY | NEOCORTICAL NEUROFIBRILLARY PATHOLOGY | AMYLOID-BETA-PEPTIDE | CEREBROSPINAL-FLUID TAU | WHITE-MATTER HYPERINTENSITIES | CREUTZFELDT-JAKOB-DISEASE | Alzheimer Disease - diagnosis | Nerve Tissue Proteins - blood | Animals | Humans | Biomarkers - blood | Nerve Tissue Proteins - genetics | Alzheimer Disease - blood | Alzheimer Disease - pathology | Immunohistochemistry | Neuroimaging | Brain | RNA-directed DNA polymerase | Transcription | Peptides | Pathogenesis | Genes | Cognitive ability | Cerebrospinal fluid | Blood | Proteins | Connective tissues | Computed tomography | Neurodegeneration | Autopsy | Lymphocytes | Immunotherapy | Dementia disorders | Bioindicators | Diagnosis | Chromosomes | Alzheimer's disease | Enzyme-linked immunosorbent assay | Age | Urine | Antigens | Pathogens | Autopsies | Neurodegenerative diseases | Connective tissue diseases | Amino acid sequence | Metabolism | Amyloid precursor protein | Pathology | Hypotheses | Acids | Tau protein | Chromosome 21 | Biomarkers | Diagnostic systems | Mutation | Platelets | Hippocampus | Reviews
Journal Article
Nature, ISSN 0028-0836, 02/2018, Volume 554, Issue 7691, pp. 249 - 254
To facilitate clinical trials of disease-modifying therapies for Alzheimer's disease, which are expected to be most efficacious at the earliest and mildest... 
NATIONAL INSTITUTE | LIFE-STYLE AIBL | ANALYTICAL PLATFORMS | QUANTIFICATION | MULTIDISCIPLINARY SCIENCES | BLOOD-BASED BIOMARKERS | DIAGNOSTIC GUIDELINES | MILD COGNITIVE IMPAIRMENT | CEREBROSPINAL-FLUID | MASS-SPECTROMETRY | ASSOCIATION WORKGROUPS | Immunoprecipitation | Humans | Male | Positron-Emission Tomography | Amyloid beta-Peptides - blood | Case-Control Studies | Alzheimer Disease - diagnosis | Brain - metabolism | Mass Spectrometry | Amyloid beta-Peptides - metabolism | Amyloid beta-Protein Precursor - metabolism | Peptide Fragments - blood | Amyloid beta-Peptides - cerebrospinal fluid | Amyloid beta-Protein Precursor - blood | Female | Biomarkers - metabolism | Peptide Fragments - metabolism | Reproducibility of Results | Peptide Fragments - cerebrospinal fluid | Cognitive Dysfunction - metabolism | Japan | Cognitive Dysfunction - blood | Biomarkers - blood | Alzheimer Disease - cerebrospinal fluid | Cost-Benefit Analysis | Alzheimer Disease - metabolism | Aged | Biomarkers - cerebrospinal fluid | Australia | Alzheimer Disease - blood | Neuroimaging | Plasma | Brain | Peptides | Cognitive ability | Clinical trials | Cerebrospinal fluid | Blood | Aging | Alzheimer's disease | Medical research | Medical imaging | Neurodegenerative diseases | Positron emission | Mass spectroscopy | Amyloid precursor protein | Studies | Biomarkers | Ligands | Scientific imaging | Alzheimers disease | Mass spectrometry | Positron emission tomography | Dementia
Journal Article
Neurobiology of Disease, ISSN 0969-9961, 2008, Volume 35, Issue 2, pp. 128 - 140
Journal Article